192 results
8-K
FENC
Fennec Pharmaceuticals Inc
21 Mar 24
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
4:02pm
, and covenants were negotiated with the principal purpose of allocating risk between the parties to the Agreement, rather than establishing matters as fact
8-K
EX-10.1
2ff3c6
21 Mar 24
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
4:02pm
424B7
0zjixlh
15 Mar 24
Prospectus with selling stockholder info
3:53pm
8-K
EX-4.1
ohdi2z50 mtxo
5 Dec 23
Fennec Announces Incremental $5 Million Investment from Petrichor
8:51pm
8-K/A
EX-10.1
dcqjarchwss x089fwez
7 Aug 23
Fennec Pharmaceuticals Announces Second Quarter 2023
10:51am
8-K
EX-10.1
g7pew
4 Aug 23
Fennec Pharmaceuticals Announces Second Quarter 2023
10:58am
424B3
ipv7t
15 Dec 22
Prospectus supplement
5:12pm